RELZIQ Trademark

Trademark Overview


On Thursday, March 6, 2003, a trademark application was filed for RELZIQ with the United States Patent and Trademark Office. The USPTO has given the RELZIQ trademark a serial number of 76494914. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, January 14, 2005. This trademark is owned by Eli Lilly and Company. The RELZIQ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, macular degeneration, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders
relziq

General Information


Serial Number76494914
Word MarkRELZIQ
Filing DateThursday, March 6, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, January 14, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 21, 2003

Trademark Statements


Goods and Servicespharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, macular degeneration, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders
Translation of Words in MarkThe mark "RELZIQ" is a coined, non-dictionary, non-foreign word with no English translation.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 21, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Sunday, May 8, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, May 6, 2005ABANDONMENT - NO USE STATEMENT FILED
Monday, June 14, 2004EXTENSION 1 GRANTED
Thursday, June 3, 2004EXTENSION 1 FILED
Thursday, June 3, 2004TEAS EXTENSION RECEIVED
Tuesday, January 13, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 21, 2003PUBLISHED FOR OPPOSITION
Wednesday, October 1, 2003NOTICE OF PUBLICATION
Thursday, August 14, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 14, 2003ASSIGNED TO EXAMINER